Literature DB >> 24022845

Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancer.

Hyeyeol Bae, Soichiro Yoshida, Yoh Matsuoka, Hiroshi Nakajima, Eisaku Ito, Hiroshi Tanaka, Miyako Oya, Takayuki Nakayama, Hideki Takeshita, Toshiki Kijima, Junichiro Ishioka, Noboru Numao, Fumitaka Koga, Kazutaka Saito, Takumi Akashi, Yasuhisa Fujii, Kazunori Kihara.   

Abstract

PURPOSE: To assess whether there is an association between the apparent diffusion coefficient (ADC) value and the pathological characteristics of prostate cancer.
METHODS: The study cohort consisted of 29 consecutive patients with prostate cancer treated with radical prostatectomy. All patients underwent diffusion-weighted MRI before the prostate biopsy. In 42 tumor foci, the associations of the ADC values with the clinicopathological characteristics and Ki-67 labeling index (LI) were analyzed.
RESULTS: High-grade cancers (Gleason score [GS] ≥ 4 + 3), larger cancers (maximum diameter (MD) ≥ 16 mm), and highly proliferating cancers (Ki-67 LI ≥ 4.43 %) had significantly lower ADC values, respectively (P < .001, P = .008, and P = .044, respectively). There was no significant difference in ADC value according to age, prostate-specific antigen, presence of extra-prostatic extension, and intra-tumoral stroma proportion. Multivariate analysis showed that GS, Ki-67 LI, and MD had independent and significant correlations with ADC value (P < .001, P = .006, and P = .002, respectively). Low ADC tumors (<0.52 × 10(-3) mm(2)/s) are likely to be high-grade cancer foci compared with high ADC tumors (relative risk: 65.2). The sensitivity and specificity of the ADC value to predict high-grade cancer foci are 81.8 and 93.5 %, respectively.
CONCLUSIONS: A low ADC value reflects the morphological and biological features of prostate cancer. Analyzing the ADC value may make it possible to more precisely predict the cancer aggressiveness of each focus before treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24022845     DOI: 10.1007/s11255-013-0557-1

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  24 in total

1.  Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.

Authors:  Aytekin Oto; Cheng Yang; Arda Kayhan; Maria Tretiakova; Tatjana Antic; Christine Schmid-Tannwald; Scott Eggener; Gregory S Karczmar; Walter M Stadler
Journal:  AJR Am J Roentgenol       Date:  2011-12       Impact factor: 3.959

2.  Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade.

Authors:  Yusuhn Kang; Seung Hong Choi; Young-Jae Kim; Kwang Gi Kim; Chul-Ho Sohn; Ji-Hoon Kim; Tae Jin Yun; Kee-Hyun Chang
Journal:  Radiology       Date:  2011-10-03       Impact factor: 11.105

3.  Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.

Authors:  Thomas Hambrock; Diederik M Somford; Henkjan J Huisman; Inge M van Oort; J Alfred Witjes; Christina A Hulsbergen-van de Kaa; Thomas Scheenen; Jelle O Barentsz
Journal:  Radiology       Date:  2011-05       Impact factor: 11.105

4.  Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI.

Authors:  Matthew J Wieduwilt; Francisco Valles; Samar Issa; Caroline M Behler; James Hwang; Michael McDermott; Patrick Treseler; Joan O'Brien; Marc A Shuman; Soonmee Cha; Lloyd E Damon; James L Rubenstein
Journal:  Clin Cancer Res       Date:  2012-01-06       Impact factor: 12.531

5.  Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer.

Authors:  Shuichiro Kobayashi; Fumitaka Koga; Kohei Kajino; Soichiro Yoshita; Chikako Ishii; Hiroshi Tanaka; Kazutaka Saito; Hitoshi Masuda; Yasuhisa Fujii; Tetsuo Yamada; Kazunori Kihara
Journal:  J Magn Reson Imaging       Date:  2013-04-15       Impact factor: 4.813

6.  Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer: a preliminary report.

Authors:  Soichiro Yoshida; Shuichiro Kobayashi; Fumitaka Koga; Junichiro Ishioka; Chikako Ishii; Hiroshi Tanaka; Yasukazu Nakanishi; Yoh Matsuoka; Noboru Numao; Kazutaka Saito; Hitoshi Masuda; Yasuhisa Fujii; Kazunori Kihara
Journal:  Eur Radiol       Date:  2013-03-15       Impact factor: 5.315

Review 7.  Diffusion-weighted MRI in the body: applications and challenges in oncology.

Authors:  Dow-Mu Koh; David J Collins
Journal:  AJR Am J Roentgenol       Date:  2007-06       Impact factor: 3.959

8.  Combination of diffusion-weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: application in patient selection for hemiablative focal therapy.

Authors:  Yoh Matsuoka; Noboru Numao; Kazutaka Saito; Hiroshi Tanaka; Jiro Kumagai; Soichiro Yoshida; Fumitaka Koga; Hitoshi Masuda; Satoru Kawakami; Yasuhisa Fujii; Kazunori Kihara
Journal:  Eur Urol       Date:  2012-10-16       Impact factor: 20.096

9.  Do apparent diffusion coefficient (ADC) values obtained using high b-values with a 3-T MRI correlate better than a transrectal ultrasound (TRUS)-guided biopsy with true Gleason scores obtained from radical prostatectomy specimens for patients with prostate cancer?

Authors:  Kazuhiro Kitajima; Satoru Takahashi; Yoshiko Ueno; Hideaki Miyake; Masato Fujisawa; Fumi Kawakami; Kazuro Sugimura
Journal:  Eur J Radiol       Date:  2013-03-19       Impact factor: 3.528

10.  Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study.

Authors:  Hashim U Ahmed; Richard G Hindley; Louise Dickinson; Alex Freeman; Alex P Kirkham; Mahua Sahu; Rebecca Scott; Clare Allen; Jan Van der Meulen; Mark Emberton
Journal:  Lancet Oncol       Date:  2012-04-17       Impact factor: 41.316

View more
  13 in total

1.  DWI and IVIM are predictors of Ki67 proliferation index: direct comparison of MRI images and pathological slices in a murine model of rhabdomyosarcoma.

Authors:  Yuan Yuan; Dewei Zeng; Yajie Liu; Juan Tao; Yu Zhang; Jie Yang; Tsendjav Lkhagvadorj; Zhenzhen Yin; Shaowu Wang
Journal:  Eur Radiol       Date:  2019-11-08       Impact factor: 5.315

2.  Diffusion-weighted MRI as a potential imaging biomarker reflecting the metastatic potential of upper urinary tract cancer.

Authors:  Y Uchida; S Yoshida; S Kobayashi; F Koga; J Ishioka; S Satoh; C Ishii; H Tanaka; Y Matsuoka; N Numao; K Saito; H Masuda; Y Fujii; K Kihara
Journal:  Br J Radiol       Date:  2014-07-30       Impact factor: 3.039

3.  Could IVIM and ADC help in predicting the KRAS status in patients with rectal cancer?

Authors:  Yanyan Xu; Qiaoyu Xu; Hongliang Sun; Tongxi Liu; Kaining Shi; Wu Wang
Journal:  Eur Radiol       Date:  2018-02-15       Impact factor: 5.315

Review 4.  The expanding landscape of diffusion-weighted MRI in prostate cancer.

Authors:  Andreas G Wibmer; Evis Sala; Hedvig Hricak; Hebert Alberto Vargas
Journal:  Abdom Radiol (NY)       Date:  2016-05

5.  Primary and metastatic ovarian cancer: Characterization by 3.0T diffusion-weighted MRI.

Authors:  Auni Lindgren; Maarit Anttila; Suvi Rautiainen; Otso Arponen; Annukka Kivelä; Petri Mäkinen; Kirsi Härmä; Kirsi Hämäläinen; Veli-Matti Kosma; Seppo Ylä-Herttuala; Ritva Vanninen; Hanna Sallinen
Journal:  Eur Radiol       Date:  2017-03-13       Impact factor: 5.315

6.  Associations between apparent diffusion coefficient (ADC) and KI 67 in different tumors: a meta-analysis. Part 2: ADCmin.

Authors:  Alexey Surov; Hans Jonas Meyer; Andreas Wienke
Journal:  Oncotarget       Date:  2018-01-04

7.  Automated prostate cancer detection via comprehensive multi-parametric magnetic resonance imaging texture feature models.

Authors:  Farzad Khalvati; Alexander Wong; Masoom A Haider
Journal:  BMC Med Imaging       Date:  2015-08-05       Impact factor: 1.930

8.  Combined PET imaging and diffusion-weighted imaging of intermediate and high-risk primary prostate carcinomas with simultaneous [18F] choline PET/MRI.

Authors:  Axel Wetter; Felix Nensa; Marcus Schenck; Philipp Heusch; Thorsten Pöppel; Andreas Bockisch; Michael Forsting; Thomas W Schlosser; Thomas C Lauenstein; James Nagarajah
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240

9.  Apparent Diffusion Coefficient (ADC) value: a potential imaging biomarker that reflects the biological features of rectal cancer.

Authors:  Yiqun Sun; Tong Tong; Sanjun Cai; Rui Bi; Chao Xin; Yajia Gu
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

Review 10.  Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer.

Authors:  Jurgen J Fütterer
Journal:  Korean J Radiol       Date:  2017-05-19       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.